Search Results - "Rérolle, J. P."

Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation by Le Meur, Y., Büchler, M., Thierry, A., Caillard, S., Villemain, F., Lavaud, S., Etienne, I., Westeel, P.‐F., De Ligny, B. H., Rostaing, L., Thervet, E., Szelag, J. C., Rérolle, J.‐P., Rousseau, A., Touchard, G., Marquet, P.

“…Efficacy and safety of mycophenolate mofetil (MMF) may be optimized with individualized doses based on therapeutic monitoring of its active metabolite,…”
Get full text

Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF—Four‐Year Results of the Postconcept Study by Lebranchu, Y., Thierry, A., Thervet, E., Büchler, M., Etienne, I., Westeel, P. F., de Ligny, B. Hurault, Moulin, B., Rérolle, J. P., Frouget, T., Girardot‐Seguin, S., Toupance, O.

“…Calcineurin inhibitor (CNI) withdrawal has been used as a strategy to improve renal allograft function. We previously reported that conversion from…”
Get full text

Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach by Daher Abdi, Z., Essig, M., Rizopoulos, D., Le Meur, Y., Prémaud, A., Woillard, J.B., Rérolle, J.P., Marquet, P., Rousseau, A.

“…This study aimed to investigate the association between longitudinal exposure to mycophenolic acid (MPA) and acute rejection (AR) risk in the first year after…”
Get full text

A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry by Benkali, K, Marquet, P, Rérolle, Jp, Le Meur, Y, Gastinel, Ln

“…LC-MALDI-TOF/TOF analysis is a potent tool in biomarkers discovery characterized by its high sensitivity and high throughput capacity. However, methods based…”
Get full text

Five‐Year Results of a Randomized Trial Comparing De Novo Sirolimus and Cyclosporine in Renal Transplantation: The Spiesser Study by Lebranchu, Y., Snanoudj, R., Toupance, O., Weestel, P.‐F., de Ligny, B. Hurault, Buchler, M., Rerolle, J.‐P., Thierry, A., Moulin, B., Subra, J.‐F., Deteix, P., Pogamp, P. Le, Finzi, L., Etienne, I.

“…Calcineurin inhibitors improve acute rejection rates and short‐term graft survival in renal transplantation, but their continuous use may be deleterious. We…”
Get full text

Donor P-gp Polymorphisms Strongly Influence Renal Function and Graft Loss in a Cohort of Renal Transplant Recipients on Cyclosporine Therapy in a Long-Term Follow-Up by Woillard, J‐B, Rerolle, J‐P, Picard, N, Rousseau, A, Guillaudeau, A, Munteanu, E, Essig, M, Drouet, M, Le Meur, Y, Marquet, P

“…Cyclosporin A (CsA) is a substrate for cytochrome P450 3A and the efflux transporter P‐glycoprotein (P‐gp; ABCB1), both abundantly expressed in the kidney. In…”
Get full text

De Novo Kidney Graft Tumors: Results From a Multicentric Retrospective National Study by Tillou, X., Doerfler, A., Collon, S., Kleinclauss, F., Patard, J.‐J., Badet, L., Barrou, B., Audet, M., Bensadoun, H., Berthoux, E., Bigot, P., Boutin, J.‐M., Bouzguenda, Y., Chambade, D., Codas, R., Dantal, J., Deturmeny, J., Devonec, M., Dugardin, F., Ferrière, J.‐M., Erauso, A., Feuillu, B., Gigante, M., Guy, L., Karam, G., Lebret, T., Neuzillet, Y., Legendre, C., Perez, T., Rerolle, J.‐P., Salomon, L., Sallusto, F., Sénéchal, C., Terrier, N., Thuret, R., Verhoest, G., Petit, J.

“…De novo tumors in renal allografts are rare and their prevalence is underestimated. We therefore analyzed renal cell carcinomas arising in renal allografts…”
Get full text

Drug-Induced Nephrotoxicity: A Frequent Cause of Hospitalization In Nephrology by Rey, A, Berrué, M, Chambaraud, T, Rerolle, J.-P, Allard, J, Essig, M, Monchaud, C

Get full text

Genome‐Wide Association Study of Acute Renal Graft Rejection by Ghisdal, L., Baron, C., Lebranchu, Y., Viklický, O., Konarikova, A., Naesens, M., Kuypers, D., Dinic, M., Alamartine, E., Touchard, G., Antoine, T., Essig, M., Rerolle, J. P., Merville, P., Taupin, J. L., Le Meur, Y., Grall‐Jezequel, A., Glowacki, F., Noël, C., Legendre, C., Anglicheau, D., Broeders, N., Coppieters, W., Docampo, E., Georges, M., Ajarchouh, Z., Massart, A., Racapé, J., Abramowicz, D., Abramowicz, M.

“…Acute renal rejection is a major risk factor for chronic allograft dysfunction and long‐term graft loss. We performed a genome‐wide association study to detect…”
Get full text

Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis by THAUNAT, O, ALYANAKIAN, M. A, VARNOUS, S, BORS, V, DAMAJ, G, REROLLE, J. P, JONDEAU, K, VARET, B, GANDJBAKHCH, I, BUZYN, A

Get full text

Bordetella holmesii bacteremia in a renal transplant recipient: emergence of a new pathogen by Chambaraud, T., Dickson, Z., Ensergueix, G., Barraud, O., Essig, M., Lacour, C., Allard, J., Bocquentin, F., Aldigier, J.C., Rerolle, J.P.

“…Bordetella holmesii is a gram‐negative rod that was initially identified in 1995. It causes bacteremia, pneumonia, and endocarditis mostly in patients with…”
Get full text

Crescentic glomerulonephritis and centrocytic lymphoma by REROLLE, J.-P, THERVET, E, BEAUFILS, H, VINCENT, F, ROUSSELOT, P, PILLEBOUT, E, LEGENDRE, C

Get full text

Tacrolimus‐induced hemolytic uremic syndrome and end‐stage renal failure after liver transplantation by Rerolle, Jean‐Philippe, Akposso, Kodzo, Lerolle, Nicolas, Mougenot, Béatrice, Ponnelle, Tibor, Rondeau, Eric, Sraer, Jean‐Daniel

“…Background. Hemolytic uremic syndrome (HUS) is a rare complication in solid organ transplantation. It can be associated with severe hypertension. Several risk…”
Get full text

Successful endoluminal thromboaspiration of renal graft venous thrombosis by Rerolle, J.P, Antoine, C, Raynaud, A, Beyssen, B, Julia, P, Duboust, A, Glotz, D

Get full text

Histologic evolution of kidney graft after combined pancreas–kidney transplantation by Rerolle, J.P, Thervet, E, Desgrandchamps, F, Nochy, D, Janin, A, Fornairon, S, Passa, P, Bedrossian, J, Legendre, C

Get full text

Successful endoluminal thrombo-aspiration of renal graft venous thrombosis by Rerolle, J P, Antoine, C, Raynaud, A, Beyssen, B, Julia, P, Duboust, A, Glotz, D

“…Renal transplant vein thrombosis is an unusual event occurring in 0.3-3% of renal transplantations. Prognosis is uniformly poor with graft loss in nearly every…”
Get more information

De novo functional renal graft carcinomas: Are they a different entity? by Tillou, X, Bensadoun, H, Bessede, T, Bigot, P, Boutin, J.-M, Bouyé, S, Codas, R, Cognard, N, Coffin, G, De Fortescu, G, Devonec, M, Erauso, A, Gaudez, F, Gigante, M, Hubert, J, Karam, G, Laurent, G, Lechevallier, E, Mousson, C, Rerolle, J.-P, Sallusto, F, Salomon, L, Sénéchal, C, Terrier, N, Timsit, M.-O, Thuret, R, Toupance, O, Verhoest, G, Viart, L, Doerfler, A

Get full text

Presentation and revascularization outcomes in patients with radiation-induced renal artery stenosis by Fakhouri, Fadi, Alanore, Agn[egrave]s La Batide, R[eacute]rolle, Jean-Philippe, Gu[eacute]ry, Bruno, Raynaud, Alain, Plouin, Pierre-Fran[ccedil]ois

“…This study analyzed the initial presentation and revascularization outcomes of patients with radiation-induced renal artery stenosis, a rare complication of…”
Get full text

Long‐term renal allograft outcome after simultaneous kidney and pancreas transplantation by Rerolle, Jean Philippe, Thervet, Eric, Anglicheau, Dany, Desgrandchamps, François, Nochy, Dominique, Janin, Anne, Fornairon, Sophie, Passa, Philippe, Bedrossian, Janine, Legendre, Christophe

“…Background. In selected young patients with type 1 diabetes mellitus and end‐stage renal failure, simultaneous pancreas and kidney (SPK) transplantation is the…”
Get full text

Incidence of Delayed Graft Function and Wound Healing Complications After Deceased-Donor Kidney Transplantation Is not Affected by De Novo Everolimus by ALBANO, Laetitia, BERTHOUX, François, BAYLE, François, FRANCOIS WESTEEL, Pierre, GLOTZ, Denis, KOSSARI, Niloufar, LEFRANCOIS, Nicole, CHARPENTIER, Bernard, BLANC, Anne-Sandrine, DI GIAMBATTISTA, Fabienne, DANTAL, Jacques, MOAL, Marie-Christine, ROSTAING, Lionel, LEGENDRE, Christophe, GENIN, Robert, TOUPANCE, Olivier, MOULIN, Bruno, MERVILLE, Pierre, REROLLE, Jean-Philippe

“…Concerns about delayed graft function (DGF) and wound healing complications with sirolimus has led to suggestions that everolimus introduction could be delayed…”
Get full text